Recalls / Firms / Mylan Institutional, Inc.
Mylan Institutional, Inc.
9 FDA drug recalls on record — 1 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-03-07 | Class II | Levothyroxine Sodium | Ongoing |
| 2025-03-07 | Class II | Levothyroxine Sodium | Ongoing |
| 2024-11-19 | Class II | Levothyroxine Sodium | Ongoing |
| 2024-11-19 | Class II | Levothyroxine Sodium | Ongoing |
| 2024-11-19 | Class II | Levothyroxine Sodium | Ongoing |
| 2024-11-19 | Class II | Levothyroxine Sodium | Ongoing |
| 2024-11-19 | Class II | Levothyroxine Sodium | Ongoing |
| 2024-11-19 | Class II | Levothyroxine Sodium | Ongoing |
| 2019-02-01 | Class I | Levoleucovorin Injection, 250 mg/25 mL, (10 mg/mL), 25 mL Single-Use Vial, Rx only, Manufa | Terminated |